IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AYODEJI I JOLAYEMI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1235490178
CMS profile
328626
Location
NEW YORK, NY

General Payments · PY2018–2024

$6,825.33

  • Reported across 220 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,274.80

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,216.00 1
Food and Beverage $1,058.80 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $2,239.47 2
Neurocrine BioSciences, Inc. $248.86 10
ITI, Inc. $208.65 12
Otsuka America Pharmaceutical, Inc. $163.89 8
Alkermes, Inc. $118.72 5
Janssen Pharmaceuticals, Inc $115.80 5
Lundbeck LLC $94.14 4
Indivior Inc. $64.84 3
Teva Pharmaceuticals USA, Inc. $20.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $153.05 8
PY2019 $293.55 15
PY2020 $455.35 23
PY2021 $905.71 46
PY2022 $864.41 39
PY2023 $878.46 39
PY2024 $3,274.80 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $26.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1120525580 CMS
Alkermes, Inc. $23.73 05/08/2024 Food and Beverage Undisputed 01/23/2026 1120525582 CMS
Alkermes, Inc. $20.83 06/27/2024 Food and Beverage Undisputed 01/23/2026 1120525584 CMS
Alkermes, Inc. $25.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 1120525586 CMS
Alkermes, Inc. $22.60 11/06/2024 Food and Beverage Undisputed 01/23/2026 1120525588 CMS
E.R. Squibb & Sons, L.L.C. $2,216.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1101217066 CMS
E.R. Squibb & Sons, L.L.C. $23.47 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101217086 CMS
Indivior Inc. $26.68 03/13/2024 Food and Beverage Undisputed 01/23/2026 1144530740 CMS
Indivior Inc. $19.08 07/02/2024 Food and Beverage Undisputed 01/23/2026 1144530742 CMS
Indivior Inc. $19.08 07/09/2024 Food and Beverage Undisputed 01/23/2026 1144530744 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.50 01/11/2024 Food and Beverage Undisputed 01/23/2026 1143251723 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.47 01/12/2024 Food and Beverage Undisputed 01/23/2026 1143251727 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.91 01/16/2024 Food and Beverage Undisputed 01/23/2026 1143251730 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.68 01/23/2024 Food and Beverage Undisputed 01/23/2026 1143251734 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.32 01/26/2024 Food and Beverage Undisputed 01/23/2026 1143251738 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.89 02/02/2024 Food and Beverage Undisputed 01/23/2026 1143251742 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.38 03/07/2024 Food and Beverage Undisputed 01/23/2026 1143251746 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.50 03/21/2024 Food and Beverage Undisputed 01/23/2026 1143251750 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.06 04/17/2024 Food and Beverage Undisputed 01/23/2026 1143251754 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.87 05/16/2024 Food and Beverage Undisputed 01/23/2026 1143251759 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.25 05/22/2024 Food and Beverage Undisputed 01/23/2026 1143251764 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.82 12/18/2024 Food and Beverage Undisputed 01/23/2026 1143251768 CMS
Janssen Pharmaceuticals, Inc $19.02 01/23/2024 Food and Beverage Undisputed 01/23/2026 1078114288 CMS
Janssen Pharmaceuticals, Inc $30.52 02/27/2024 Food and Beverage Undisputed 01/23/2026 1078115626 CMS
Janssen Pharmaceuticals, Inc $19.61 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078113920 CMS
Janssen Pharmaceuticals, Inc $20.94 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078113510 CMS
Janssen Pharmaceuticals, Inc $25.71 09/04/2024 Food and Beverage Undisputed 01/23/2026 1078114048 CMS
Lundbeck LLC $26.19 01/31/2024 Food and Beverage Undisputed 01/23/2026 1145929652 CMS
Lundbeck LLC $19.19 04/25/2024 Food and Beverage Undisputed 01/23/2026 1145929654 CMS
Lundbeck LLC $13.93 07/25/2024 Food and Beverage Undisputed 01/23/2026 1145929656 CMS
Lundbeck LLC $34.83 09/17/2024 Food and Beverage Undisputed 01/23/2026 1145929658 CMS
Neurocrine Biosciences, Inc. $20.86 01/10/2024 Food and Beverage Undisputed 01/23/2026 1150855140 CMS
Neurocrine Biosciences, Inc. $32.32 01/30/2024 Food and Beverage Undisputed 01/23/2026 1150822367 CMS
Neurocrine Biosciences, Inc. $26.84 03/27/2024 Food and Beverage Undisputed 01/23/2026 1150834014 CMS
Neurocrine Biosciences, Inc. $26.25 04/24/2024 Food and Beverage Undisputed 01/23/2026 1150836092 CMS
Neurocrine Biosciences, Inc. $8.07 05/15/2024 Food and Beverage Undisputed 01/23/2026 1150884259 CMS
Neurocrine Biosciences, Inc. $35.69 05/27/2024 Food and Beverage Undisputed 01/23/2026 1150818340 CMS
Neurocrine Biosciences, Inc. $28.22 06/12/2024 Food and Beverage Undisputed 01/23/2026 1150830054 CMS
Neurocrine Biosciences, Inc. $30.84 07/09/2024 Food and Beverage Undisputed 01/23/2026 1150824594 CMS
Neurocrine Biosciences, Inc. $32.44 07/31/2024 Food and Beverage Undisputed 01/23/2026 1150822222 CMS
Neurocrine Biosciences, Inc. $7.33 11/02/2024 Food and Beverage Undisputed 01/23/2026 1150885111 CMS
Otsuka America Pharmaceutical, Inc. $20.68 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118916667 CMS
Otsuka America Pharmaceutical, Inc. $21.75 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118916669 CMS
Otsuka America Pharmaceutical, Inc. $20.87 07/24/2024 Food and Beverage Undisputed 01/23/2026 1118916671 CMS
Otsuka America Pharmaceutical, Inc. $21.66 08/15/2024 Food and Beverage Undisputed 01/23/2026 1118916673 CMS
Otsuka America Pharmaceutical, Inc. $1.75 09/25/2024 Food and Beverage Undisputed 01/23/2026 1118916675 CMS
Otsuka America Pharmaceutical, Inc. $24.89 09/25/2024 Food and Beverage Undisputed 01/23/2026 1118916677 CMS
Otsuka America Pharmaceutical, Inc. $23.19 10/31/2024 Food and Beverage Undisputed 01/23/2026 1118916679 CMS
Otsuka America Pharmaceutical, Inc. $29.10 12/11/2024 Food and Beverage Undisputed 01/23/2026 1118916681 CMS
Teva Pharmaceuticals USA, Inc. $20.43 01/17/2024 Food and Beverage Undisputed 01/23/2026 1151585590 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.